These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25566828)

  • 1. Inhibition of TGFβ type I receptor activity facilitates liver regeneration upon acute CCl4 intoxication in mice.
    Karkampouna S; Goumans MJ; Ten Dijke P; Dooley S; Kruithof-de Julio M
    Arch Toxicol; 2016 Feb; 90(2):347-57. PubMed ID: 25566828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion of liver regeneration and anti‑fibrotic effects of the TGF‑β receptor kinase inhibitor galunisertib in CCl4‑treated mice.
    Masuda A; Nakamura T; Abe M; Iwamoto H; Sakaue T; Tanaka T; Suzuki H; Koga H; Torimura T
    Int J Mol Med; 2020 Jul; 46(1):427-438. PubMed ID: 32377696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced effectivity of an ALK5-inhibitor after cell-specific delivery to hepatic stellate cells in mice with liver injury.
    van Beuge MM; Prakash J; Lacombe M; Post E; Reker-Smit C; Beljaars L; Poelstra K
    PLoS One; 2013; 8(2):e56442. PubMed ID: 23441194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo.
    Bouquet F; Pal A; Pilones KA; Demaria S; Hann B; Akhurst RJ; Babb JS; Lonning SM; DeWyngaert JK; Formenti SC; Barcellos-Hoff MH
    Clin Cancer Res; 2011 Nov; 17(21):6754-65. PubMed ID: 22028490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis.
    de Gouville AC; Boullay V; Krysa G; Pilot J; Brusq JM; Loriolle F; Gauthier JM; Papworth SA; Laroze A; Gellibert F; Huet S
    Br J Pharmacol; 2005 May; 145(2):166-77. PubMed ID: 15723089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes.
    Weng HL; Ciuclan L; Liu Y; Hamzavi J; Godoy P; Gaitantzi H; Kanzler S; Heuchel R; Ueberham U; Gebhardt R; Breitkopf K; Dooley S
    Hepatology; 2007 Oct; 46(4):1257-70. PubMed ID: 17657819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice.
    Niu L; Cui X; Qi Y; Xie D; Wu Q; Chen X; Ge J; Liu Z
    PLoS One; 2016; 11(5):e0156090. PubMed ID: 27224286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of transforming growth factor-beta and its receptors in hepatocytes and nonparenchymal cells of rat liver after CCl4 administration.
    Date M; Matsuzaki K; Matsushita M; Sakitani K; Shibano K; Okajima A; Yamamoto C; Ogata N; Okumura T; Seki T; Kubota Y; Kan M; McKeehan WL; Inoue K
    J Hepatol; 1998 Apr; 28(4):572-81. PubMed ID: 9566825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling.
    Goumans MJ; Valdimarsdottir G; Itoh S; Lebrin F; Larsson J; Mummery C; Karlsson S; ten Dijke P
    Mol Cell; 2003 Oct; 12(4):817-28. PubMed ID: 14580334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal regulation of vessel stability by MMP14 and TGFbeta.
    Sounni NE; Dehne K; van Kempen L; Egeblad M; Affara NI; Cuevas I; Wiesen J; Junankar S; Korets L; Lee J; Shen J; Morrison CJ; Overall CM; Krane SM; Werb Z; Boudreau N; Coussens LM
    Dis Model Mech; 2010; 3(5-6):317-32. PubMed ID: 20223936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
    Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
    Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGFβ1-induced SMAD2/3 and SMAD1/5 phosphorylation are both ALK5-kinase-dependent in primary chondrocytes and mediated by TAK1 kinase activity.
    van Caam A; Madej W; Garcia de Vinuesa A; Goumans MJ; Ten Dijke P; Blaney Davidson E; van der Kraan P
    Arthritis Res Ther; 2017 May; 19(1):112. PubMed ID: 28569204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined induction of liver progenitor cells and the suppression of stellate cells by small molecules reverts chronic hepatic dysfunction.
    Huang WJ; Zhou X; Fu GB; Ding M; Wu HP; Zeng M; Zhang HD; Xu LY; Gao Y; Wang HY; Yan HX
    Theranostics; 2021; 11(11):5539-5552. PubMed ID: 33859762
    [No Abstract]   [Full Text] [Related]  

  • 15. Tgf-beta type I receptor (Alk5) kinase inhibitors in oncology.
    Ling LE; Lee WC
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2190-202. PubMed ID: 21619541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular crosstalk mediated by platelet-derived growth factor BB and transforming growth factor β during hepatic injury activates hepatic stellate cells.
    Mekala S; Tulimilli SV; Geesala R; Manupati K; Dhoke NR; Das A
    Can J Physiol Pharmacol; 2018 Aug; 96(8):728-741. PubMed ID: 29558627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta1 protects against pulmonary artery endothelial cell apoptosis via ALK5.
    Lu Q
    Am J Physiol Lung Cell Mol Physiol; 2008 Jul; 295(1):L123-33. PubMed ID: 18456797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-independent transforming growth factor-β type I receptor signalling mediates type I collagen-induced epithelial-mesenchymal transition.
    DeMaio L; Buckley ST; Krishnaveni MS; Flodby P; Dubourd M; Banfalvi A; Xing Y; Ehrhardt C; Minoo P; Zhou B; Crandall ED; Borok Z
    J Pathol; 2012 Mar; 226(4):633-44. PubMed ID: 21984393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model.
    Weber LW; Boll M; Stampfl A
    Crit Rev Toxicol; 2003; 33(2):105-36. PubMed ID: 12708612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
    Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
    Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.